Publications by authors named "Haifaa Ibrahim AlHumedi"
Article Synopsis
- The REPLENISH trial aims to determine if higher protein supplementation in critically ill patients improves 90-day survival rates compared to moderate protein intake.
- The study will involve randomizing 2,502 mechanically ventilated patients to receive either higher (2-2.4 g/kg/day) or moderate (0.8-1.2 g/kg/day) protein levels, with a focus on all-cause mortality and quality of life outcomes.
- The research has received ethical approval and will share findings through journals and conferences to influence future clinical practices.
Background: Protein intake is recommended in critically ill patients to mitigate the negative effects of critical illness-induced catabolism and muscle wasting. However, the optimal dose of enteral protein remains unknown. We hypothesize that supplemental enteral protein (1.
View Article and Find Full Text PDF